DS-7113b phase III study A DS-7113b immediate release (IR) tablet long-term study in patients with cancer pain
Latest Information Update: 07 Jun 2016
At a glance
- Drugs Hydromorphone (Primary)
- Indications Cancer pain
- Focus Therapeutic Use
- Sponsors Daiichi Sankyo Company
- 07 Jun 2016 New trial record